CPC A61K 35/28 (2013.01) [A61K 8/981 (2013.01); A61K 8/983 (2013.01); A61K 35/12 (2013.01); A61K 35/16 (2013.01); A61K 35/22 (2013.01); A61Q 19/00 (2013.01); A61Q 19/08 (2013.01); A61K 2800/74 (2013.01); A61K 2800/86 (2013.01)] | 13 Claims |
1. A topical composition for treating wounds comprising an effective amount of an enriched population of intact microvesicles collected from polyethylene glycol precipitation of a mesenchymal stem cell supernatant or a biological fluid;
wherein the mesenchymal stem cells are derived from bone marrow;
wherein the microvesicles range in size from 2 nm to 5000 nm;
wherein the topical composition further comprises a storage solution;
wherein the intact microvesicles result in increased migration of non-proliferating cultured fibroblasts in a cell migration assay when administered to the non-proliferating cultured fibroblasts; and
wherein said effective amount of isolated microvesicles results in regeneration of at least one skin tissue in the skin wound.
|